Translation in progress…

We need your help to fund the first clinical trial on Lafora disease.

THIS CLINICAL TRIAL COULD GIVE OUR CHILDREN A NEW LEASE OF LIFE !

ION283 is the most successful drug to date for destroying LAFORA bodies.

We need your help to advance research !!!

More information

HERE

Page d’accueil EN - Page d’accueil EN - Page d’accueil EN -Marche des sorcieres qv9jbogvwxkaundiuody8dy46rgxwl2yrvp9r696rg - Page d’accueil EN

Welcome to the France Lafora website.

 
We invite you to go to News to follow the latest information on research and all the initiatives undertaken to raise awareness of the disease and raise funds.
 
The Lafora disease is a genetic disorder that is classified as a progressive myoclonic epilepsy. It is an extremely rare, life-threatening neurodegenerative disease..
The 1st manifestations of this disease generally occur during second childhood and are characterised by epileptic seizures and myoclonic jerks. The course of the disease is marked by slow, progressive degeneration of the nervous system and deterioration of brain function, leading to complete dependence. The patient is then unable to move, speak or eat alone. Life expectancy can be as low as 10 years after the first neurological signs appear.
Loss of autonomy is very difficult for our children. When life was opening its arms to them, they find themselves trapped, with the disease disrupting all their plans. For them, there is no future. They will have to stop their studies, their sporting activities, they won’t be able to drive, they won’t be able to have a love life, their circle of friends will dwindle, they won’t become the young men or women that we, their parents, imagined them to be.
There is currently no treatment on the market that can cure or even slow the progression of the disease. Anti-epileptic and anti-myoclonic treatments are purely symptomatic. The protocols proposed to patients are based on their comfort, the aim being to limit generalised seizures, occipital seizures and action and rest myoclonus.
For our Lafora children, time is running out.
The research is therefore our one and only HOPE.
 

FIGHTING THE RARE

This is the latest medium to be released on 26/06/2023 to raise awareness of Lafora disease. It includes testimonials from all those involved in the disease (parents, researchers, etc.).

Sous-titré en Français
Play Video
Page d’accueil EN - Page d’accueil EN - Page d’accueil EN -Djao - Page d’accueil EN
Page d’accueil EN - Page d’accueil EN - Page d’accueil EN -Matys scaled - Page d’accueil EN
Page d’accueil EN - Page d’accueil EN - Page d’accueil EN -Mathilda - Page d’accueil EN
Page d’accueil EN - Page d’accueil EN - Page d’accueil EN -20190303 140158 - Page d’accueil EN
Page d’accueil EN - Page d’accueil EN - Page d’accueil EN -Giulian - Page d’accueil EN
Page d’accueil EN - Page d’accueil EN - Page d’accueil EN -Marhilda Dja et Giulian - Page d’accueil EN
Page d’accueil EN - Page d’accueil EN - Page d’accueil EN -Mathilda Giulian - Page d’accueil EN
Page d’accueil EN - Page d’accueil EN - Page d’accueil EN -Julie - Page d’accueil EN
Page d’accueil EN - Page d’accueil EN - Page d’accueil EN -Djao 2 - Page d’accueil EN
Page d’accueil EN - Page d’accueil EN - Page d’accueil EN -20210210 145403 scaled - Page d’accueil EN
Page d’accueil EN - Page d’accueil EN - Page d’accueil EN -Bene - Page d’accueil EN
Page d’accueil EN - Page d’accueil EN - Page d’accueil EN -Robin - Page d’accueil EN
Page d’accueil EN - Page d’accueil EN - Page d’accueil EN -received 1466913347403541 - Page d’accueil EN
Djao
Matys
Mathilda
Robin1
Giulian
Marhilda Dja et Giulian
Mathilda Giulian
Julie
Djao 2
Robin2
Bene
Robin
received_1466913347403541
Page d’accueil EN - Page d’accueil EN - Page d’accueil EN -svg+xml;base64,PHN2ZyB3aWR0aD0iMzIiIGhlaWdodD0iMzIiIHZpZXdCb3g9IjAgMCAzMiAzMiIgeG1sbnM9Imh0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnIj4KICAgIDxwYXRoIGQ9Ik0xMS40MzMgMTUuOTkyTDIyLjY5IDUuNzEyYy4zOTMtLjM5LjM5My0xLjAzIDAtMS40Mi0uMzkzLS4zOS0xLjAzLS4zOS0xLjQyMyAwbC0xMS45OCAxMC45NGMtLjIxLjIxLS4zLjQ5LS4yODUuNzYtLjAxNS4yOC4wNzUuNTYuMjg0Ljc3bDExLjk4IDEwLjk0Yy4zOTMuMzkgMS4wMy4zOSAxLjQyNCAwIC4zOTMtLjQuMzkzLTEuMDMgMC0xLjQybC0xMS4yNTctMTAuMjkiCiAgICAgICAgICBmaWxsPSIjMzU3Y2JkIiBvcGFjaXR5PSIxIiBmaWxsLXJ1bGU9ImV2ZW5vZGQiLz4KPC9zdmc+ - Page d’accueil EN
Page d’accueil EN - Page d’accueil EN - Page d’accueil EN -svg+xml;base64,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 - Page d’accueil EN